Trastuzumab Recruiting Phase 1 Trials for Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02057133A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread